Mesenchymal stem cells ameliorate myocardial fibrosis in diabetic cardiomyopathy via the secretion of prostaglandin E2

BACKGROUND: Diabetic cardiomyopathy (DCM) is a cardiac complication of long-term uncontrolled diabetes and is characterized by myocardial fibrosis and abnormal cardiac function. Mesenchymal stem cells (MSCs) are multipotent cells with immunoregulatory and secretory functions in diabetes and heart di...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Stem Cell Res Ther
Main Authors: Jin, Liyuan, Zhang, Jinying, Deng, Zihui, Liu, Jiejie, Han, Weidong, Chen, Guanghui, Si, Yiling, Ye, Ping
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2020
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7079514/
https://ncbi.nlm.nih.gov/pubmed/32183879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-020-01633-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares